Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
Francesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma
Yuta Asano, Joshua Veatch, Megan McAfee, et al.
Nature Communications
|
September 26, 2018
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
K G Paulson, V Voillet, M S McAfee, et al.
Nature Communications
|
June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Francesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Nature Medicine
|
June 26, 2019
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G Chapuis, Daniel N Egan, Merav Bar, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
3D pathology-guided microdissection
Huai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Nature Methods
|
June 22, 2026
3D pathology-guided microdissection
Huai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome change
Siavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications
|
February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity
Siavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Science Translational Medicine
|
February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Medrxiv : the Preprint Server for Health Sciences
|
January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
Francesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma
Yuta Asano, Joshua Veatch, Megan McAfee, et al.
Nature Communications
|
September 26, 2018
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
K G Paulson, V Voillet, M S McAfee, et al.
Nature Communications
|
June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Francesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Nature Medicine
|
June 26, 2019
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G Chapuis, Daniel N Egan, Merav Bar, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
3D pathology-guided microdissection
Huai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Nature Methods
|
June 22, 2026
3D pathology-guided microdissection
Huai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome change
Siavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications
|
February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity
Siavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Science Translational Medicine
|
February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Page
of 15